Clinical Trial Update: Safety and Efficacy Study of Nitric Oxide for Inhalation on Chronic Lung Disease in Premature Babies [Phase 3]

View source ↗

Summary

Phase 3 trial result update for inhaled nitric oxide in chronic lung disease of premature infants; study completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lung Disease of Prematurity

Drugs mentioned

• Nitric Oxide for Inhalation

Snippet

Sponsor: Mallinckrodt | Conditions: Lung Disease | Phase 3 | Status: COMPLETED | Results posted: 2010-10-18